These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21089528)

  • 1. [Mechanisms of immune evasion by Streptococcus pyogenes].
    Terao Y; Kawabata S
    Tanpakushitsu Kakusan Koso; 2009 Jun; 54(8 Suppl):982-7. PubMed ID: 21089528
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular analyses of the development mechanisms of severe Streptococcus pyogenes infections].
    Terao Y
    Nihon Saikingaku Zasshi; 2008 Dec; 63(2-4):391-8. PubMed ID: 19317228
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanisms and manifestations of population variability in Streptococcus pyogenes].
    Kaminskiĭ GD; Beliakov VD
    Vestn Akad Med Nauk SSSR; 1986; (7):10-7. PubMed ID: 2428180
    [No Abstract]   [Full Text] [Related]  

  • 4. Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein.
    Carlsson F; Berggård K; Stålhammar-Carlemalm M; Lindahl G
    J Exp Med; 2003 Oct; 198(7):1057-68. PubMed ID: 14517274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein.
    Courtney HS; Hasty DL; Dale JB
    Mol Microbiol; 2006 Feb; 59(3):936-47. PubMed ID: 16420362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Don't forget about Streptococcus pyogenes! (comment on Microbes Infect. 5 (2003) 1329-1335).
    Collin M
    Microbes Infect; 2004 Mar; 6(3):336; author reply 337. PubMed ID: 15026018
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor.
    Johnsson E; Berggård K; Kotarsky H; Hellwage J; Zipfel PF; Sjöbring U; Lindahl G
    J Immunol; 1998 Nov; 161(9):4894-901. PubMed ID: 9794423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptococcus pyogenes Employs Strain-dependent Mechanisms of C3b Inactivation to Inhibit Phagocytosis and Killing of Bacteria.
    Agrahari G; Liang Z; Glinton K; Lee SW; Ploplis VA; Castellino FJ
    J Biol Chem; 2016 Apr; 291(17):9181-9. PubMed ID: 26945067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group A streptococcus epidemiology and vaccine implications.
    Cohen-Poradosu R; Kasper DL
    Clin Infect Dis; 2007 Oct; 45(7):863-5. PubMed ID: 17806050
    [No Abstract]   [Full Text] [Related]  

  • 10. Critical role for complement receptor 3 (CD11b/CD18), but not for Fc receptors, in killing of Streptococcus pyogenes by neutrophils in human immune serum.
    Nilsson M; Weineisen M; Andersson T; Truedsson L; Sjöbring U
    Eur J Immunol; 2005 May; 35(5):1472-81. PubMed ID: 15832298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertional inactivation of virR in Streptococcus pyogenes M49 demonstrates that VirR functions as a positive regulator of streptococcal C5a peptidase and M protein in OF+ strains.
    McLandsborough LA; Cleary PP
    Dev Biol Stand; 1995; 85():149-52. PubMed ID: 8586166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host-pathogen interactions in Streptococcus pyogenes infections, with special reference to puerperal fever and a comment on vaccine development.
    Areschoug T; Carlsson F; Stålhammar-Carlemalm M; Lindahl G
    Vaccine; 2004 Dec; 22 Suppl 1():S9-S14. PubMed ID: 15576204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptococcal M5 protein prevents neutrophil phagocytosis by interfering with CD11b/CD18 receptor-mediated association and signaling.
    Weineisen M; Sjöbring U; Fällman M; Andersson T
    J Immunol; 2004 Mar; 172(6):3798-807. PubMed ID: 15004185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway.
    Carlsson F; Sandin C; Lindahl G
    Mol Microbiol; 2005 Apr; 56(1):28-39. PubMed ID: 15773976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Group A Streptococcal M1 Protein Provides Resistance against the Antimicrobial Activity of Histones.
    Döhrmann S; LaRock CN; Anderson EL; Cole JN; Ryali B; Stewart C; Nonejuie P; Pogliano J; Corriden R; Ghosh P; Nizet V
    Sci Rep; 2017 Feb; 7():43039. PubMed ID: 28220899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of group A streptococci in mice and efficacy of locally administered streptococcal vaccines.
    Bronze MS; McKinsey DS; Beachey EH; Dale JB
    Trans Assoc Am Physicians; 1988; 101():88-92. PubMed ID: 3077732
    [No Abstract]   [Full Text] [Related]  

  • 17. Evolution of the emm gene family: virulence gene clusters in group A streptococci.
    Hollingshead SK; Bessen DE
    Dev Biol Stand; 1995; 85():163-8. PubMed ID: 8586169
    [No Abstract]   [Full Text] [Related]  

  • 18. [Structural basis for streptococcal toxic shock syndrome].
    Machebœuf P; Ghosh P
    Med Sci (Paris); 2011 Oct; 27(10):814-6. PubMed ID: 22027416
    [No Abstract]   [Full Text] [Related]  

  • 19. Activation of granulocytes by phorbol-12-myristate-14-acetate (PMA) enhances phagocytosis of Streptococcus pyogenes.
    Schnitzler N; Schweizer K; Podbielski A; Haase G; Spellerberg B; Holland R; Lütticken R
    Adv Exp Med Biol; 1997; 418():897-902. PubMed ID: 9331794
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular structure and immunochemistry of streptococcal M-protein].
    Ookuni H
    Tanpakushitsu Kakusan Koso; 1990 Nov; 35(15):2839-51. PubMed ID: 1701908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.